Breaking News

Slingshot Biosciences, Cellares Partner on Cell Therapy Manufacturing 

To combine TruCytes Biomarker Controls with the Cell Q platform to enhance quality and automation.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cellares Cell Q platform

Cellares Cell Q platform

Slingshot Biosciences, a company developing precision-engineered cell mimic controls, entered a strategic collaboration with Cellares, an integrated development and manufacturing organization. The partnership combines Slingshot’s TruCytes Biomarker controls into Cellares’ Cell Q, a fully automated quality-control (QC) testing platform purpose-built to scale with the Cell Shuttle, a fully automated manufacturing platform. TruCytes biomarker controls represent a major advance in standardized re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters